40 completed, 12 unknown, 7 recruiting, 6 terminated. 32 Phase 4, 11 Phase 3, 9 Not applicable, 4 Phase 1, 4 Phase 2.
Follow Clozapine: new trials by email Literature Review of Clozapine trials Research Report on Clozapine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential Treatment Approaches for Treatment-Resistant Schizophrenia [Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride - Treatment-resistant Schizophrenia | Phase 3 | Recruiting | Shanghai Mental Health Center | 300 | 2026-09-01 | 2026-11-05 |
| A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease gene therapy, clozapine - Parkinson Disease (PD), Gene Therapy | Early Phase 1 | Not yet recruiting | Ruijin Hospital | 6 | 2025-08-01 | 2025-07-25 |
| Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder | Phase 4 | Active not recruiting | Dr. Stavroula Rakitzi | 84 | 2025-06-04 | 2026-05-01 |
| Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder | Phase 3 | Terminated | Dr. Inge Winter | 1 | 2025-04-27 | 2026-11-05 |
| Biomarkers to Enhance Early Schizophrenia Treatment aripiprazole, risperidone, clozapine - Schizophenia Disorder | Phase 4 | Recruiting | Northwell Health | 180 | 2024-09-04 | 2026-07-31 |
| The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. Clozapine, Second-line Antipsychotics (treatment as usual) - Schizophrenia and Related Disorders, Early Treatment-Resistance | Phase 4 | Recruiting | Dr. Inge Winter | 418 | 2024-08-01 | 2025-09-26 |
| Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT Aripiprazole 10 MG - Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia | Phase 4 | Unknown | All India Institute of Medical Sciences, Bhubaneswar | 60 | 2023-08-20 | 2023-07-20 |
| An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia | Phase 4 | Terminated | Ohio State University | 5 | 2023-08-16 | 2026-02-25 |
| Observation of Clozapine Treatment Safety in Bipolar Disorder. Clozapine - Bipolar Disorder | Enrolling by invitation | Medical University of Gdansk | 30 | 2023-02-23 | 2023-08-25 | |
| Characterizing Response to Antipsychotics in Schizophrenia Olanzapine, Clozapine - Schizophrenia, Schizoaffective Disorder | Unknown | The Royal Ottawa Mental Health Centre | 40 | 2023-01-01 | 2023-12-06 | |
| Effects of Buspirone Combined With Clozapine Control group (clozapine, placebo), Low-dose group (buspirone tablets, clozapine), High-dose group (buspirone tablets, clozapine) - Schizophrenia | Early Phase 1 | Completed | Chuanfu Song | 46 | 2022-05-01 | 2025-04-02 |
| Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial Clozapine, treatment as usual - Schizophrenia, Schizoaffective Disorder | Phase 4 | Recruiting | New York State Psychiatric Institute | 280 | 2022-03-17 | 2026-05-04 |
| CLOZAPINE Response in Biotype-1 clozapine, risperidone - Schizophrenia, Schizoaffective Disorder | Phase 4 | Recruiting | University of Texas Southwestern Medical Center | 524 | 2022-03-01 | 2026-05-11 |
| Biomarkers in Clozapine-responding Schizophrenia Clozapine - Schizophrenia, Psychosis | Phase 4 | Recruiting | Jimmi Nielsen | 200 | 2021-02-28 | 2026-01-20 |
| Pharmacokinetics of Clozapine and Norclozapine and the Effect of Pantoprazole clozapine, pantoprazole - Healthy Volunteers - Male and Female | Phase 1 | Completed | Universiti Sains Malaysia | 33 | 2021-02-06 | 2025-12-04 |
| Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18 Clozaril 100 mg (Clozapine), WID-CLZ18 - Schizophrenia | Phase 1 | Completed | Whanin Pharmaceutical Company | 33 | 2021-01-15 | 2023-05-16 |
| SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia Clozapine, MECT, DBS - Treatment-resistant Schizophrenia | Phase 3 | Unknown | Shanghai Mental Health Center | 162 | 2020-12-01 | 2020-08-27 |
| Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis Clozapine, haloperidol, pimozide, olanzapine, risperidone, amisulpride - Psychosis, Intellectual Disability | Phase 2 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 75 | 2020-11-26 | 2024-03-20 |
| Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder Clozapine, Olanzapine - Psychosis, Substance Use Disorders | Phase 4 | Unknown | Augusta University | 100 | 2020-07-01 | 2020-03-23 |
| Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database Clozapine - Lymphoma, Leukemia | Unknown | University Hospital, Caen | 1000000 | 2019-03-01 | 2019-08-30 |
Showing 20 of 72. Sign in to see all of them.
Schizophrenia (52) · Psychotic Disorders (17) · Bipolar Disorder (10) · Schizophrenia, Treatment-Resistant (7) · Marijuana Abuse (3) · Substance-Related Disorders (3) · Aggression (2) · Anxiety Disorders (2) · Depression (2) · Depressive Disorder, Major (2) · Drug-Related Side Effects and Adverse Reactions (2) · Intellectual Disability (2) · Metabolic Syndrome (2) · Parkinson Disease (2) · Adenoviridae Infections (1)
National Institute of Mental Health (NIMH) (5) · Shanghai Mental Health Center (5) · Centre for Addiction and Mental Health (4) · Dartmouth-Hitchcock Medical Center (3) · Harvard Medical School (HMS and HSDM) (3) · Northwell Health (3) · All India Institute of Medical Sciences, Bhubaneswar (2) · Dr. Inge Winter (2) · Novartis (2) · Anders Fink-Jensen, MD, DMSci (1) · Augusta University (1) · Azur Pharma, Inc (1) · Beersheva Mental Health Center (1) · Canadian Network for Observational Drug Effect Studies, CNODES (1) · Central South University (1)
United States (28) · Canada (9) · China (8) · Israel (5) · South Korea (4) · Spain (3) · Denmark (2) · Germany (2) · Italy (2) · United Kingdom (2) · Austria (1) · Brazil (1) · France (1) · Greece (1) · India (1)
Alan I Green, MD (4) · Gary Remington, MD, PhD (2) · Alan Green, MD (1) · Alan I. Green, MD (1) · Alasdair Barr, Ph.D (1) · Alexander Grinshpoon, MD, MHA, PhD (1) · Anatoly Kreinin, MD, Phd (1) · Anders Fink-Jensen, MD, DMSci (1) · Ariel Graff, MD, PhD (1) · Baruch Spivak, MD (1) · Benedicto Crespo Facorro, Professor (1) · Bennett L Leventhal, MD (1) · Bo-Hyun Yoon (1)
PMID 10372604, PMID 10492856, PMID 15968344, PMID 16172203, PMID 16380684, PMID 16585434, PMID 16585435, PMID 16633199, PMID 16754835, PMID 16818861, PMID 17151158, PMID 17151159, PMID 17187911, PMID 17909124, PMID 18794642, PMID 19640511, PMID 19837567, PMID 20816031, PMID 20819983, PMID 20868641, PMID 21208584, PMID 21369751, PMID 22000938, PMID 22152404, PMID 22207632, PMID 22290266, PMID 22316567, PMID 23235268, PMID 23682213, PMID 23727135, PMID 24028745, PMID 24030617, PMID 24183751, PMID 24400912, PMID 24524169, PMID 24569099, PMID 24581419, PMID 24581550, PMID 24614374, PMID 24630140, PMID 24726579, PMID 24850369, PMID 24862257, PMID 24949994, PMID 25064681, PMID 25075930, PMID 25157964, PMID 25400359, PMID 25562591, PMID 25567425
R01MH049891 (2), 2015 (1), 2023 (1), N01MH090001 (1), N01MH90001 (1), P01HD026927 (1), R01DA013196 (1), R01DA032533 (1), R01MH052376 (1), R01MH060229 (1), R01MH060390 (1), R01MH120317 (1), R01MH134883 (1)